Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells

• Published in: Cancer Immunology, Immunotherapy Vol. 70; no. 5; pp. 1451 - 1464
• Main Authors: Sadeghlar, Farsaneh, Vogt, Annabelle, Mohr, Raphael U., Mahn, Robert, van Beekum, Katrin, Kornek, Miroslaw, Weismüller, Tobias J., Branchi, Vittorio, Matthaei, Hanno, Toma, Marieta, Schmidt-Wolf, I. G. H., Kalff, Jörg C., Strassburg, Christian P., González-Carmona, Maria A.
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.05.2021; Springer Nature B.V
• Subjects: Apoptosis; Bile; Bile ducts; Buffy coat; Cancer Research; CD40 antigen; CD40 Antigens - genetics; CD40 Antigens - metabolism; CD40 Ligand - genetics; CD40 Ligand - metabolism; CD40L protein; Cell activation; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Chemokines; Cholangiocarcinoma; Cholangiocarcinoma - immunology; Colorectal cancer; Colorectal carcinoma; Colorectal Neoplasms - immunology; Cytokines; Cytokines - metabolism; Cytotoxicity; Cytotoxicity, Immunologic; Dendritic cells; Dendritic Cells - immunology; Effector cells; Enzyme-linked immunosorbent assay; Flow cytometry; Humans; Immune checkpoint; Immunology; Immunomodulation; Immunotherapy; Immunotherapy - methods; Interleukin 10; Liver cancer; Lymphocyte Activation; Lymphocytes T; Lysates; Medicine; Medicine & Public Health; Metastases; Oncology; Original; Original Article; Pancreatic cancer; Pancreatic carcinoma; Pancreatic Neoplasms - immunology; PD-1 protein; Signal Transduction; Surface markers; T-Lymphocytes, Cytotoxic - immunology; Th1 Cells - immunology; Th1-Th2 Balance; Th2 Cells - immunology; Tumor cells; Tumors; Hepatocellular carcinoma; Immune checkpoint; Pancreatic carcinoma; Dendritic cells; Immunotherapy; Cholangiocarcinoma
• ISSN: 0340-7004; 1432-0851
• DOI: 10.1007/s00262-020-02746-x

Introduction Gastrointestinal (GI) malignancies, such as cholangiocarcinoma, pancreatic carcinoma, and metastatic colorectal carcinoma, have a poor prognosis and effective therapeutic approaches are still challenging. Checkpoint inhibition with PD-1 or PDL-1 antibodies revealed promising results in different tumor entities; however, only few patients with GI tumors can potentially benefit from PD1/PDL1 inhibiting immunotherapy. Further immunotherapeutic strategies for GI malignancies are urgently needed. The aim of this study was to demonstrate that in vitro activation of the immune checkpoint CD40/CD40L can improve DC action towards bile duct, pancreas, and colorectal carcinoma. Methods Human DC were isolated from buffy coats from healthy donors, pulsed with tumor lysates and then transduced with adenoviruses encoding human CD40L (Ad-hCD40L). Using transwell assays, the effects of (m)CD40L on DC immunoactivation compared to (s)CD40L were analyzed. Surface marker and cytokine/chemokine expression were measured by flow cytometry, ELISA and cytokine arrays. Capacity of Ad-hCD40L-transduced DC to induce tumor-specific effector cells was tested using MTT proliferation assay and cytotoxicity assays. Apoptosis induction on tumor cells after culturing with supernatants of Ad-hCD40L-transduced DC was analyzed by flow cytometry. Results Ad-hCD40L transduction induced a high expression of (s)CD40L and (m)CD40L on DC and seemed to induce a strong cellular CD40/CD40L interaction among DC, leading to the formation of cell aggregates. Due to the CD40/CD40L interaction, a significant upregulation of DC maturation markers and a Th1-shift on cytokines/chemokines in the supernatant of DC were achieved. Interestingly, a pure Th1-shift was only achieved, when a cellular CD40/CD40L interaction among DC took place. (s)CD40L induced almost no upregulation of maturation markers and rather resulted in a Th2-cytokine expression, such as IL-10. Correspondingly, (m)CD40L-expressing DC led to significant proliferation and stimulation of tumor-specific effector cells with increased cytotoxicity towards pancreatic, bile duct and colorectal tumor cells. Supernatants of Ad-hCD40L-transduced DC could also induce apoptosis in the different tumor cells in vitro. Conclusion Stimulation of the immune checkpoint CD40L/CD40 by endogenous expression of (m)CD40L provokes a cellular interaction, which increases the immunomodulatory capacity of DC. A Th1 cytokine/chemokine expression is induced, leading to a significant proliferation and enabling cytotoxicity of effector cells towards human bile duct, pancreatic and colorectal tumor cells. The present data point to the promising approach for DC-based immunotherapy of gastrointestinal malignances by activating the CD40/CD40L immune checkpoint.